Tandem Diabetes Care (TNDM) Inventory (2013 - 2026)

Tandem Diabetes Care (TNDM) has 14 years of Inventory data on file, last reported at $126.4 million in Q1 2026.

• For the quarter ending Q1 2026, Inventory fell 10.46% year-over-year to $126.4 million; the trailing twelve-month figure through Mar 2026 stood at $126.4 million (down 10.46% YoY), and the FY2025 full-year result was $128.8 million, down 13.93% from the prior year.
• Inventory for Q1 2026 stood at $126.4 million, down from $128.8 million in the prior quarter.
• Across five years, Inventory topped out at $161.7 million in Q2 2024 and bottomed at $80.0 million in Q1 2022.
• The 5-year median for Inventory is $141.2 million (2025), against an average of $132.8 million.
• The widest annual swing landed in 2023, when Inventory jumped 67.54%; it then decreased 13.93% in 2025.
• A 5-year view of Inventory shows it stood at $111.1 million in 2022, then jumped by 42.14% to $157.9 million in 2023, then dropped by 5.27% to $149.6 million in 2024, then slipped by 13.93% to $128.8 million in 2025, then declined by 1.84% to $126.4 million in 2026.
• The last three Inventory figures came in at $126.4 million (Q1 2026), $128.8 million (Q4 2025), and $137.3 million (Q3 2025), per Business Quant data.

Peer Comparison